Health Care: Drugs

Immunoclin Corp (IMCL: OTC)

$4.4 n/a | n/a%
04/09/14 - 01:57 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
IMCLSector Avg.S&P 500
n/a029.08
Price Performance History (% change):
3 Mo1 Yr3 Yr
000
GROWTH12 Mo3 YrCAGR
Revenue00
Net Income00
EPS0n/a
Earnings for IMCL:
EBITDA-39.00
REVENUE0.00
Average Earnings Estimates
Qtr (12/08) Qtr (03/09) FY (12/08) FY (12/09)
Average Estimate $0.26 $0.28 $1.18 $1.39
Number of Analysts 8 1 8 9
High Estimate $0.30 $0.28 $1.26 $1.62
Low Estimate $0.21 $0.28 $1.03 $1.20
Prior Year $0.41 $0.33 $1.43 $1.18
Growth Rate (Year over Year) -36.89% -15.15% -17.83% 18.68%
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter